Evidence map›Paper›PMID 33092306›Full record

ReviewPathogens (Basel, Switzerland)2020

Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health.

Srinivas Reddy Pallerla, Dominik Harms, Reimar Johne, Daniel Todt, Eike Steinmann, Mathias Schemmerer, Jürgen J Wenzel, Jörg Hofmann, James Wai Kuo Shih, Heiner Wedemeyer and 2 more

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Srinivas Reddy PallerlaInstitute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany.ORCID 0000-0003-1669-1515
Dominik HarmsDivision of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin 13353, Germany.
Reimar JohneDepartment Biological Safety, Unit Viruses in Food, German Federal Institute for Risk Assessment, Berlin 10589, Germany.ORCID 0000-0001-9597-6724
Daniel TodtDepartment of Molecular and Medical Virology, Ruhr University Bochum, Bochum 44801, Germany.ORCID 0000-0002-3564-1014
Eike SteinmannDepartment of Molecular and Medical Virology, Ruhr University Bochum, Bochum 44801, Germany.
Mathias SchemmererInstitute of Clinical Microbiology and Hygiene, National Consultant Laboratory for HAV and HEV, University Medical Center Regensburg, Regensburg 93053, Germany.
Jürgen J WenzelInstitute of Clinical Microbiology and Hygiene, National Consultant Laboratory for HAV and HEV, University Medical Center Regensburg, Regensburg 93053, Germany.
Jörg HofmannInstitute of Virology, Charité Universitätsmedizin Berlin, Labor Berlin-Charité-Vivantes GmbH, Berlin 13353, Germany.
James Wai Kuo ShihXiamen Innovax Biotech Co., Ltd., Haicang, Xiamen 361022, China.
Heiner WedemeyerDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover 30623, Germany.
C-Thomas BockInstitute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany.ORCID 0000-0002-2773-486X
Thirumalaisamy P VelavanInstitute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany.ORCID 0000-0002-9809-9883

Funding

Bundesministerium für Gesundheit ZMVI1-2518FSB705Bundesministerium für Gesundheit ZMVI1-2519GHP711Bundesministerium für Wissenschaft und Forschung BMBF01DP17047Bundesministerium für Wissenschaft und Forschung BMBF01DP19006AClaussen-Simon-Stiftung Dissertation PlusFAZIT Stiftung Promotions Stipendium
6 · The paper itself

Abstract

Infection with hepatitis E virus (HEV) represents the most common source of viral hepatitis globally. Although infecting over 20 million people annually in endemic regions, with major outbreaks described since the 1950s, hepatitis E remains an underestimated disease. This review gives a current view of the global circulation and epidemiology of this emerging virus. The history of HEV, from the first reported enteric non-A non-B hepatitis outbreaks, to the discovery of the viral agent and the molecular characterization of the different human pathogenic genotypes, is discussed. Furthermore, the current state of research regarding the virology of HEV is critically assessed, and the challenges towards prevention and diagnosis, as well as clinical risks of the disease described. Together, these points aim to underline the significant impact of hepatitis E on global health and the need for further in-depth research to better understand the pathophysiology and its role in the complex disease manifestations of HEV infection.

Indexed as

epidemiologyglobal healthhepatitis Einfectionoutbreak

Identifiers

PMID33092306
PMCPMC7589794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.